Literature DB >> 29191513

International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017.

Shuji Isaji1, Shugo Mizuno2, John A Windsor3, Claudio Bassi4, Carlos Fernández-Del Castillo5, Thilo Hackert6, Aoi Hayasaki2, Matthew H G Katz7, Sun-Whe Kim8, Masashi Kishiwada2, Hirohisa Kitagawa9, Christoph W Michalski6, Christopher L Wolfgang10.   

Abstract

This statement was developed to promote international consensus on the definition of borderline resectable pancreatic ductal adenocarcinoma (BR-PDAC) which was adopted by the National Comprehensive Cancer Network (NCCN) in 2006, but which has changed yearly and become more complicated. Based on a symposium held during the 20th meeting of the International Association of Pancreatology (IAP) in Sendai, Japan, in 2016, the presenters sought consensus on issues related to BR-PDAC. We defined patients with BR-PDAC according to the three distinct dimensions: anatomical (A), biological (B), and conditional (C). Anatomic factors include tumor contact with the superior mesenteric artery and/or celiac artery of less than 180° without showing stenosis or deformity, tumor contact with the common hepatic artery without showing tumor contact with the proper hepatic artery and/or celiac artery, and tumor contact with the superior mesenteric vein and/or portal vein including bilateral narrowing or occlusion without extending beyond the inferior border of the duodenum. Biological factors include potentially resectable disease based on anatomic criteria but with clinical findings suspicious for (but unproven) distant metastases or regional lymph nodes metastases diagnosed by biopsy or positron emission tomography-computed tomography. This also includes a serum carbohydrate antigen (CA) 19-9 level more than 500 units/ml. Conditional factors include the patients with potentially resectable disease based on anatomic and biologic criteria and with Eastern Cooperative Oncology Group (ECOG) performance status of 2 or more. The definition of BR-PDAC requires one or more positive dimensions (e.g. A, B, C, AB, AC, BC or ABC). The present definition acknowledges that resectability is not just about the anatomic relationship between the tumor and vessels, but that biological and conditional dimensions are also important. The aim in presenting this consensus definition is also to highlight issues which remain controversial and require further research.
Copyright © 2017 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anatomical definition; Biological definition; Borderline resectable; Conditional definition; Pancreatic ductal adenocarcinoma

Mesh:

Year:  2017        PMID: 29191513     DOI: 10.1016/j.pan.2017.11.011

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  95 in total

1.  An Improved Staging System for Locally Advanced Pancreatic Cancer: A Critical Need in the Multidisciplinary Era.

Authors:  Marc W Fromer; Jenci Hawthorne; Prejesh Philips; Michael E Egger; Charles R Scoggins; Kelly M McMasters; Robert C G Martin
Journal:  Ann Surg Oncol       Date:  2021-06-04       Impact factor: 5.344

2.  Pancreatectomy with Vascular Resection After Neoadjuvant FOLFIRINOX: Who Survives More Than a Year After Surgery?

Authors:  Laurent Sulpice; Olivier Turrini; Jonathan Garnier; Fabien Robin; Jacques Ewald; Ugo Marchese; Damien Bergeat; Karim Boudjema; Jean-Robert Delpero
Journal:  Ann Surg Oncol       Date:  2021-01-18       Impact factor: 5.344

3.  A Prognostic Score for Predicting Survival in Patients With Pancreatic Head Adenocarcinoma and Distal Cholangiocarcinoma.

Authors:  Edoardo Maria Muttillo; Antonio Ciardi; Paolina Saullo; Raffaele Troiano; Gabriele Masselli; Marianna Guida; Alessandra Tortora; Isabella Sperduti; Giulio Marinello; Piero Chirletti; Roberto Caronna
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

4.  [Palliative therapy concepts for pancreatic carcinoma].

Authors:  M Brunner; R Grützmann; G F Weber
Journal:  Chirurg       Date:  2018-09       Impact factor: 0.955

5.  Frailty is associated with poor prognosis after resection for pancreatic cancer.

Authors:  Kosuke Mima; Hiromitsu Hayashi; Shigeki Nakagawa; Takashi Matsumoto; Shotaro Kinoshita; Kazuki Matsumura; Fumimasa Kitamura; Norio Uemura; Yosuke Nakao; Rumi Itoyama; Takayoshi Kaida; Katsunori Imai; Yo-Ichi Yamashita; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2021-07-07       Impact factor: 3.402

6.  Pathological analysis of the superior mesenteric artery boundary in preoperative computed tomography of resectable pancreatic head adenocarcinoma.

Authors:  Meng Lu; Chun-Hui Yuan; Ling-Fu Zhang; Lian-Yuan Tao; Ying Peng; Li-Mei Guo; Gang Li; Dian-Rong Xiu
Journal:  Oncol Lett       Date:  2019-04-18       Impact factor: 2.967

7.  Preoperative Chemoradiation for Borderline Resectable Pancreatic Cancer: The New Standard?

Authors:  Matthew Hg Katz; Michael P Kim; Ching-Wei Tzeng; Jeffrey E Lee
Journal:  Ann Surg       Date:  2018-08       Impact factor: 12.969

8.  Distal Pancreatectomy with Celiac Axis Resection (Modified Appleby Procedure) and Arterial Reconstruction for Locally Advanced Pancreatic Adenocarcinoma After FOLFIRINOX Chemotherapy and Chemoradiation Therapy.

Authors:  Pierre-Emmanuel Colombo; François Quenet; Pierre Alric; Anne Mourregot; Mathias Neron; Fabienne Portales; Philippe Rouanet; Guillaume Carrier
Journal:  Ann Surg Oncol       Date:  2020-06-25       Impact factor: 5.344

9.  Hepatic artery resection and reconstruction using the right gastroepiploic artery during pancreaticoduodenectomy in advanced pancreatic cancer.

Authors:  Yoshitaro Shindo; Yukio Tokumitsu; Satoshi Matsukuma; Hiroto Matsui; Masao Nakajima; Nobuaki Suzuki; Shigeru Takeda; Yoshinobu Hoshii; Hiroaki Nagano
Journal:  Langenbecks Arch Surg       Date:  2021-04-13       Impact factor: 3.445

10.  Perioperative Outcomes of Robotic Pancreaticoduodenectomy: a Propensity-Matched Analysis to Open and Laparoscopic Pancreaticoduodenectomy.

Authors:  A Floortje van Oosten; Ding Ding; Joseph R Habib; Ahmer Irfan; Ryan K Schmocker; Elisabetta Sereni; Benedict Kinny-Köster; Michael Wright; Vincent P Groot; I Quintus Molenaar; John L Cameron; Martin Makary; Richard A Burkhart; William R Burns; Christopher L Wolfgang; Jin He
Journal:  J Gastrointest Surg       Date:  2020-11-17       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.